Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $919.02 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $230.65 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $199.56 | 2 | $0 (2018) |
| PORTOLA PHARMACEUTICALS, INC. | $150.31 | 2 | $0 (2019) |
| Genentech USA, Inc. | $98.29 | 1 | $0 (2017) |
| Stryker Corporation | $55.18 | 1 | $0 (2021) |
| Henry Schein, Inc. | $48.18 | 1 | $0 (2019) |
| Allergan Inc. | $47.79 | 2 | $0 (2018) |
| Global Blood Therapeutics, Inc. | $29.38 | 2 | $0 (2021) |
| Inari Medical, Inc. | $22.72 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $22.22 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.81 | 2 | Inari Medical, Inc. ($22.72) |
| 2022 | $22.22 | 1 | Janssen Pharmaceuticals, Inc ($22.22) |
| 2021 | $68.60 | 2 | Stryker Corporation ($55.18) |
| 2020 | $28.82 | 2 | Global Blood Therapeutics, Inc. ($15.96) |
| 2019 | $198.49 | 3 | PORTOLA PHARMACEUTICALS, INC. ($150.31) |
| 2018 | $367.12 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($199.56) |
| 2017 | $190.96 | 2 | Genentech USA, Inc. ($98.29) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: VTE | ||||||
| 04/29/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/03/2021 | Stryker Corporation | SPINEJACK (Device) | Food and Beverage | In-kind items and services | $55.18 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 03/01/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 08/12/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 01/08/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2019 | Henry Schein, Inc. | — | Food and Beverage | In-kind items and services | $48.18 | General |
| 04/25/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $8.87 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 01/22/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $141.44 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 11/07/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | LUCEMYRA (Drug) | Food and Beverage | In-kind items and services | $99.59 | General |
| Category: PAIN MEDICINE | ||||||
| 10/23/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/26/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/11/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/07/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $105.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/28/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $92.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/26/2017 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $98.29 | General |
| Category: Metabolism & Primary Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 352 | 372 | $553,217 | $40,876 |
| 2022 | 5 | 586 | 679 | $710,583 | $68,789 |
| 2021 | 4 | 417 | 441 | $434,469 | $42,016 |
| 2020 | 4 | 457 | 493 | $497,334 | $46,624 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 180 | 193 | $348,558 | $26,245 | 7.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 138 | 145 | $179,669 | $12,905 | 7.2% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 34 | 34 | $24,990 | $1,726 | 6.9% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 275 | 327 | $498,052 | $49,521 | 9.9% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 82 | 99 | $101,416 | $9,662 | 9.5% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 74 | 84 | $56,644 | $4,734 | 8.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 20 | 21 | $37,303 | $3,936 | 10.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 135 | 148 | $17,168 | $935.01 | 5.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 198 | 213 | $322,908 | $32,370 | 10.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 61 | 63 | $64,638 | $6,308 | 9.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 46 | 49 | $33,467 | $2,617 | 7.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 112 | 116 | $13,456 | $721.28 | 5.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 223 | 242 | $366,872 | $36,218 | 9.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 62 | 69 | $70,794 | $6,326 | 8.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 63 | 68 | $46,444 | $3,318 | 7.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 109 | 114 | $13,224 | $761.34 | 5.8% |
About Dr. Randall Herrin, MD
Dr. Randall Herrin, MD is a Emergency Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942231261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randall Herrin, MD has received a total of $919.02 in payments from pharmaceutical and medical device companies, with $42.81 received in 2024. These payments were reported across 18 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($919.02).
As a Medicare-enrolled provider, Herrin has provided services to 1,812 Medicare beneficiaries, totaling 1,985 services with total Medicare billing of $198,305. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Tulsa, OK
- Active Since 07/05/2006
- Last Updated 07/08/2007
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1942231261
Products in Payments
- ELIQUIS (Drug) $230.65
- ANDEXXA (Biological) $150.31
- XIFAXAN (Drug) $99.97
- LUCEMYRA (Drug) $99.59
- Activase (Biological) $98.29
- SPINEJACK (Device) $55.18
- OXBRYTA (Drug) $29.38
- DALVANCE (Drug) $24.47
- TEFLARO (Drug) $23.32
- FLOWTRIEVER CATHETER, S (Device) $22.72
- XARELTO (Drug) $22.22
- DIFICID (Drug) $14.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Tulsa
Darnell Blackmon, Md, MD
Emergency Medicine — Payments: $87,410
Dr. Jeffrey Goodloe, M.d, M.D
Emergency Medicine — Payments: $11,859
Jeffrey Johnson, Md, MD
Emergency Medicine — Payments: $5,156
Trung Pham, D.o, D.O
Emergency Medicine — Payments: $3,718
William Gray, Md, MD
Emergency Medicine — Payments: $1,769
Dr. Patricia Ellison-Brown, Do, DO
Emergency Medicine — Payments: $1,507